Yüklüyor......

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment of chronic myeloid leukemia (CML). Optimal conditioning intensity for allo-HCT for CML in the era of tyrosine kinase inhibitors (TKIs) is unknown. Using the Center for International Blood and Marrow Transpla...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Chhabra, Saurabh, Ahn, Kwang Woo, Hu, Zhen-Huan, Jain, Sandeep, Assal, Amer, Cerny, Jan, Copelan, Edward A., Daly, Andrew, DeFilipp, Zachariah, Gadalla, Shahinaz M., Gale, Robert Peter, Ganguly, Siddhartha, Hamilton, Betty K., Hildebrandt, Gerhard Carl, Hsu, Jack W., Inamoto, Yoshihiro, Kanate, Abraham S., Khoury, H. Jean, Lazarus, Hillard M., Litzow, Mark R., Nathan, Sunita, Olsson, Richard F., Pawarode, Attaphol, Ringden, Olle, Rowe, Jacob M., Saad, Ayman, Savani, Bipin N., Schouten, Harry C., Seo, Sachiko, Shah, Nirav N., Solh, Melhem, Stuart, Robert K., Ustun, Celalettin, Woolfrey, Ann E., Yared, Jean A., Alyea, Edwin P., Kalaycio, Matt E., Popat, Uday, Sobecks, Ronald M., Saber, Wael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6234373/
https://ncbi.nlm.nih.gov/pubmed/30396912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018024844
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!